{"date":"2025-10-21","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7850-2025-10-21-1720-18x4lmu","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-10-21","time":"17:20:27","subject":"本公司受邀參加寬量國際主辦之「18th QIC CEO Week」","clause":"第30款","fact_date":"2025-10-22","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-10-21 17:20，「本公司受邀參加寬量國際主辦之「18th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2025-10-21-1713-l24vny","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-10-21","time":"17:13:22","subject":"本公司接獲越南合作夥伴VRISG通知，脂肪來源間質幹細胞(GXIPC1)治療第一型糖尿病完成第一期臨床試驗結案報告，獲越南衛生部證明書(補充113/12/09重訊)。","clause":"第44款","fact_date":"2025-10-21","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2025-10-21 17:13，「本公司接獲越南合作夥伴VRISG通知，脂肪來源間質幹細胞(GXIPC1)治療第一型糖尿病完成第一期臨床試驗結案報告，獲越」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-10-21-1659-al0978","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-10-21","time":"16:59:14","subject":"本公司受邀參加台新證券舉辦之「2025年度法人說明會」","clause":"第12款","fact_date":"2025-10-23","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-10-21 16:59，「本公司受邀參加台新證券舉辦之「2025年度法人說明會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-10-21-1625-1asrcg1","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-10-21","time":"16:25:37","subject":"公告本公司獨立董事辭任審計委員會職務","clause":"第6款","fact_date":"2025-10-21","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-10-21 16:25，「公告本公司獨立董事辭任審計委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-10-21-1624-qrsqda","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-10-21","time":"16:24:04","subject":"公告本公司獨立董事辭任","clause":"第6款","fact_date":"2025-10-21","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-10-21 16:24，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-10-21-1500-73cmmk","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-10-21","time":"15:00:47","subject":"公告本公司買回庫藏股已執行完畢","clause":"第35款","fact_date":"2025-10-21","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-10-21 15:00，「公告本公司買回庫藏股已執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-10-21-1441-1gnwafw","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-10-21","time":"14:41:47","subject":"本公司受邀參加櫃買中心與永豐金證券舉辦之「台灣投資論壇」線上海外法人說明會","clause":"第12款","fact_date":"2025-10-22","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-10-21 14:41，「本公司受邀參加櫃買中心與永豐金證券舉辦之「台灣投資論壇」線上海外法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-10-21-1350-h8i4s4","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-10-21","time":"13:50:16","subject":"生華科受邀參加國泰證券舉辦之生技企業日","clause":"第12款","fact_date":"2025-10-28","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-10-21 13:50，「生華科受邀參加國泰證券舉辦之生技企業日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-10-21-1201-1fqkmsr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-10-21","time":"12:01:18","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-10-21 12:01，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}